Login
← Go Back
Beta Drugs
BETA · Pharma > Pharmaceuticals & Drugs · Chairman: Rahul Batra · MD: Rahul Batra · Listing date: Oct. 13, 2017
Stock Price vs Company Growth
1d
5.4%
1w
14.9%
1m
0.6%
3m
61.6%
6m
40.8%
1y
226.9%
5y
42.5%
all
41.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,110 5.4%
1,171
2,674
Company Overview
Sales
407 Cr
Growth: 5.5%
Profit after Tax
45.1 Cr
Growth: 17.7%
Small Cap
2,339 Cr
P/E: 48.3x
Industry P/E: 32.3x
Fundamentals
Sales (Cr) ₹ 407
Growth 5.5%
EBITDA 20.1%
P/S 5.7x
Dividend 0.0%
P/E 48.3x
Book Value ₹ 219
PEG Ratio 8.9x
ROE 20.1%
P/B 9.6x
Shareholding Pattern
Institutions
Suryavanshi Commotrade Private Limited
6.71 %
Ashish Kacholia
4.93 %
Bsas Infotech Ltd
1.27 %
Ankush Kedia
1.12 %
Onkar Singh
1.05 %
Promoters
Vijay Kumar Batra
65.69 %
Rahul Batra
0.36 %
Varun Batra
0.35 %
Neeraj Batra
0.28 %
Heena Batra
0.01 %
Others
Increase    Decrease    No change
Company Profile Detailed
Beta Drugs is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers. Beta Drugs is primarily engaged in the manufacturing of oncology products. The products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.
Investors (7)
onkar.si...
airavat....
bsas.inf...
Followers (1)
random